Negligible Pharmacokinetic Interaction of Red Ginseng and Losartan, an Antihypertensive Agent, in Sprague-Dawley Rats

REFERENCES

• Abdel-Fattah, L., Abdel-Aziz, L., and Gaied, M. 2015. Enhanced spectrophotometric determination of Losartan potassium based on its physicochemical interaction with cationic surfactant. Spectrochim. Acta A Mol. Biomol. Spectrosc. 136: 178–184.
   PubMed Web of Science ®Google Scholar
• Bu, Q. T., Zhang, W. Y., Chen, Q. C., Zhang, C. Z., Gong, X. J., Liu, W. C., Li, W., and Zheng, Y. N. 2012. Anti-diabetic effect of ginsenoside Rb(3) in alloxan-induced diabetic mice. Med. Chem. 8: 934–941.
   PubMed Web of Science ®Google Scholar
• Choi, D. H., Li, C., and Choi, J. S. 2010. Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: Possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin. J. Pharm. Pharmacol. 62: 908–914.
   PubMed Web of Science ®Google Scholar
• Choi, J., Kim, T. H., Choi, T. Y., and Lee, M. S. 2013. Ginseng for health care: A systematic review of randomized controlled trials in Korean literature. PLoS ONE 8: e59978.
   PubMed Web of Science ®Google Scholar
• Coon, J. T., and Ernst, E. 2002. Panax ginseng: A systematic review of adverse effects and drug interactions. Drug Safety 25: 323–344.
   PubMed Web of Science ®Google Scholar
• Deppe, S., Ripperger, A., Weiss, J., Ergun, S., and Benndorf, R. A. 2014. Impact of genetic variability in the ABCG2 gene on ABCG2 expression, function, and interaction with AT1 receptor antagonist telmisartan. Biochem. Biophys. Res. Commun. 443: 1211–1217.
   PubMed Web of Science ®Google Scholar
• Ekins, S., Ring, B. J., Grace, J., McRobie-Belle, D. J., and Wrighton, S. A. 2000. Present and future in vitro approaches for drug metabolism. J. Pharmacol. Toxicol. Methods 44: 313–324.
   PubMed Web of Science ®Google Scholar
• Fleisher, D., Li, C., Zhou, Y., Pao, L. H., and Karim, A. 1999. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clin. Pharmacokinet. 36: 233–254.
   PubMed Web of Science ®Google Scholar
• Goldberg, M. R., Lo, M. W., Bradstreet, T. E., Ritter, M. A., and Höglund, P. 1995. Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist. Eur. J. Clin. Pharmacol. 49: 115–119.
   PubMed Web of Science ®Google Scholar
• He, B., Chen, P., Yang, J., Yun, Y., Zhang, X., Yang, R., and Shen, Z. 2012. Neuroprotective effect of 20(R)-ginsenoside Rg(3) against transient focal cerebral ischemia in rats. Neurosci. Lett. 526: 106–111.
   PubMed Web of Science ®Google Scholar
• Hong, S. Y., Kim, J. Y., Ahn, H. Y., Shin, J. H., and Kwon, O. 2012. Panax ginseng extract rich in ginsenoside protopanaxatriol attenuates blood pressure elevation in spontaneously hypertensive rats by affecting the Akt-dependent phosphorylation of endothelial nitric oxide synthase. J. Agric. Food. Chem. 60: 3086–3091.
   PubMed Web of Science ®Google Scholar
• Hwang, J. T., Lee, M. S., Kim, H. J., Sung, M. J., Kim, H. Y., Kim, M. S., and Kwon, D. Y. 2009. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother. Res. 23: 262–266.
   PubMed Web of Science ®Google Scholar
• Jang, D. J., Lee, M. S., Shin, B. C., Lee, Y. C., and Ernst, E. 2008. Red ginseng for treating erectile dysfunction: A systematic review. Br. J. Clin. Pharmacol. 66: 444–450.
   PubMed Web of Science ®Google Scholar
• Jeong, H. U., Kwon, S. S., Kong, T. Y., Kim, J. H., and Lee, H. S. 2014. Inhibitory effects of cedrol, β-cedrene, and thujopsene on cytochrome P450 enzyme activities in human liver microsomes. J. Toxicol. Environ. Health A 77: 1522–1532.
   PubMed Web of Science ®Google Scholar
• Joh, E. H., Lee, I. A., Jung, I. H., and Kim, D. H. 2011. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—The key step of inflammation. Biochem. Pharmacol. 82: 278–286.
   PubMed Web of Science ®Google Scholar
• Kang, S. Y., Schini-Kerth, V. B., and Kim, N. D. 1995. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life. Sci. 56: 1577–1586.
   PubMed Web of Science ®Google Scholar
• Katoh, M., Nakajima, M., Shimada, N., Yamazaki, H., and Yokoi, T. 2000. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: Prediction of in vivo drug-drug interactions. Eur. J. Clin. Pharmacol. 55: 843–852.
   PubMed Web of Science ®Google Scholar
• Kim, N. D., Kang, S. Y., and Schini, V. B. 1994. Ginsenosides evoke endothelium-dependent vascular relaxation in rat aorta. Gen. Pharmacol. 25: 1071–1077.
   PubMedGoogle Scholar
• Kim, S. G., Lee, A. J., Bae, S. H., Kim, S. M., Lee, J. H., Kim, M. J., and Jang, H. B. 2014. Total extract of Korean red ginseng facilitates human bone marrow hematopoietic colony formation in vitro. Blood Res. 49: 177–181.
   Google Scholar
• Kim, T. H., Choi, Y. S., Choi, Y. H., and Kim, Y. G. 2013. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of e367 acetamidocapric acid in rat plasma. Toxicol. Res. 29: 203–209.
   Google Scholar
• Lee, H. U., Bae, E. A., Han, M. J., Kim, N. J., and Kim, D. H. 2005. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury. Liver Int. 25: 1069–1073.
   PubMed Web of Science ®Google Scholar
• Lee, Y. Y., Park, J. S., Jung, J. S., Kim, D. H., and Kim., H. S. 2013. Anti-inflammatory effect of ginsenoside Rg5 in lipopolysaccharide-stimulated BV2 microglial cells. Int. J. Mol. Sci. 14: 9820–9833.
   PubMed Web of Science ®Google Scholar
• Li, Y., Tang, J., Khatibi, N. H., Zhu, M., Chen, D., Zheng, W., and Wang, S. 2010. Ginsenoside Rbeta1 reduces neurologic damage, is anti-apoptotic, and down-regulates p53 and BAX in subarachnoid hemorrhage. Curr. Neurovasc. Res. 7: 85–94.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Zhang, J. W., Li, W., Ma, H., Sun, J., Deng, M. C., and Yang, L. 2006. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. Toxicol. Sci. 91: 356–364.
   PubMed Web of Science ®Google Scholar
• Ministry of Food and Drug Safety in Korea. 2013. Functional food information. http://www.foodnara.go.kr/hfoodi
   Google Scholar
• Pan, C., Huo, Y., An, X., Singh, G., Chen, M., Yang, Z., Pu, J., and Li, J. 2012. Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation. Vascul. Pharmacol. 56: 150–158.
   PubMed Web of Science ®Google Scholar
• Rouhou, M. C., Charest-Tardif, G., and Haddad, S. 2015. In vivo effects of naproxen, salicylic acid, and valproic acid on the pharmacokinetics of trichloroethylene and metabolites in rats. J. Toxicol. Environ. Health. A. 78: 671–684.
   PubMed Web of Science ®Google Scholar
• Ryu, S. H., Kim, J. W., Kim, Y. S., Lee, S. H., Cho, Y. B., Kim, Y. G., and Kim, K.-B. 2014. Negligible pharmacokinetic interaction of red ginseng and amlodipine Sprague-Dawley rats. J. Toxicol. Environ. Health. A 77: 1372–1383.
   PubMed Web of Science ®Google Scholar
• Saw, C. L., Yang, A. Y., Cheng, D. C., Boyanapalli, S. S., Su, Z. Y., Khor, T. O., Gao, S., Wang, J., Jiang, Z. H. and Kong, A. N. 2012. Pharmacodynamics of ginsenosides: Antioxidant activities, activation of Nrf2, and potential synergistic effects of combinations. Chem. Res. Toxicol. 25: 1574–1580.
   PubMed Web of Science ®Google Scholar
• Singh, B. N. 1999. Effects of food on clinical pharmacokinetics. Clin. Pharmacokinet. 37:213–255.
   PubMed Web of Science ®Google Scholar
• Tan, S., Zhou, F., Li, N., Dong, Q., Zhang, X., Ye, X., Guo, J., Chen, B., and Yu, Z. 2013. Anti-fatigue effect of ginsenoside Rb1 on postoperative fatigue syndrome induced by major small intestinal resection in rat. Biol. Pharm. Bull. 31: 2024–2027.
   Google Scholar
• Tang, W., Zhang, Y., Gao, J., Ding, X. and Gao, S. 2008. The anti-fatigue effect of 20(R)-ginsenoside Rg3 in mice by intranasally administration. Biol. Pharm. Bull. 31: 2024–2027.
   PubMed Web of Science ®Google Scholar
• Thomas, J. A. 1995. Drug–nutrient interactions. Nutr. Rev. 53: 271–282.
   PubMed Web of Science ®Google Scholar
• Valcke, M., and Haddad, S. 2015. Assessing human variability in kinetics for exposures to multiple environmental chemicals: A physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene. J. Toxicol. Environ. Health A 78: 409–431.
   PubMed Web of Science ®Google Scholar
• Yuan, Y., Zhang, H., Ma, W., Sun, S., Wang, B., Zhao, L., Zhang, G., and Chai, Y. 2013. Influence of compound danshen tablet on the pharmacokinetics of losartan and its metabolite EXP3174 by liquid chromatography coupled with mass spectrometry. Biomed. Chromatogr. 27: 1219–1224.
   PubMed Web of Science ®Google Scholar
• Zhu, J., Jiang, Y., Wu, L., Lu, T., Xu, G., and Liu. X. 2012. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience. 202: 342–351.
   PubMed Web of Science ®Google Scholar
• Zhu, M., Chan, K. W., Ng, L. S., Chang, Q., Chang, S., and Li. R. C. 1999. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J. Pharm. Pharmacol. 51: 175–180.
   PubMed Web of Science ®Google Scholar